?1 prior routine of chemotherapy for advanced breast most cancers and across the entire trial, past publicity to any FGFR inhibitor, key surgical procedure or radiotherapy in four months prior to very first dose of review treatment and using powerful inhibitors or inducers of CYP3A4 or CYP2D6. Any of the next cardiac standards precluded people ente